Cáncer colorrectal: Circunstancias inductoras (etiología) y caminos de realización (patogenia)

Revista Clinica Espanola

Volumn 200, Issue 11, 2000, Pages 605-616

  Sanchez Fayos Calabuig P ^a,b   Juzgado Lucas, D ^a   Bosch Esteva, O ^a   Gonzalez Guirado A ^a   Porres Cubero, J C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Fund Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

COLON DISEASE; COLORECTAL TUMOR; DIETARY FIBER; DNA REPAIR; FAT INTAKE; FRUIT; GENETIC PREDISPOSITION; GENETICS; HUMAN; ONCOGENE; REVIEW; SEX DIFFERENCE; TUMOR SUPPRESSOR GENE; VEGETABLE;

CARCINOGENS; COLONIC DISEASES; COLORECTAL NEOPLASMS; DIETARY FATS; DIETARY FIBER; DNA REPAIR; FRUIT; GENES, APC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ONCOGENES; SEX FACTORS; VEGETABLES;

EID: 0034331743     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2565(00)70019-1     Document Type: Review

References (116)

1. Burkitt D. Related disease-related cause? Lancet 1969; 2:1.229-1.231.
2. Boring CC, Squies TS, Tong T, et al. Cancer statistics, 1994. Cancer J for Clinicians 1994; 44:7-26.
3. Mosson BC. The polyp-cancer sequence in the large bowel. Proc R Soc Med 1974; 67:451-457.
4. Hamilton RS. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem 1992; 16:41-46.
5. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991; 51:1.564-1.567.
6. Shpitz B, Hay K, Medline A, et al. Natural history of aberrant crypt foci. Dis Colin Rectum 1996; 39:763-767.
7. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238:193-197.
8. Vogelstein B, Fearon ER, Stanley BA, et al. Genetic alterations during colorrectal tumor development. N Engl J Med 1988; 319:525-532.
9. Jass JR. Colorectal adenoma progression and genetic change: is there a link? Ann Med 1995; 27:301-306.
10. Peto R. Epidemiology, multistage models and short term mutagenesis tests. En: Origins of human cancer. New York: Cold Spring Harbor, 1977; 1.403-1.428.
11. Princhard PJ, Tjandra JJ. Colorectal cancer. Gastroenterology 1998; 169:493-498.
12. Midgley R, Kerr D. Colorectal cancer. Lancet 1999; 353:391-399.
13. Breslier RS, Kim YS. Malignant neoplasms of the large intestine. En: Textbook of gastroenterology. Philadelphia: JB Lippincott Company, 1991; 1.906-1.961.
14. Boyle P, Zaridze DG, Smans M. Descriptive epidemiology of colorectal cancer. Int J Cancer 1985; 36:9-18.
15. Bosch FJ, Benito E. Epidemiología del cáncer de colon. En: Revisiones en cáncer I. Madrid: Arán Ediciones, SA, 1990; 341-347.
16. Luk GD. Epidemiology and etiology of colorectal neoplasia. Current Opinion in Gastroenterol 1992; 8:19-24.
17. Potter JD, Slattery ML, Bostick RM, et al. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993; 15:499-545.
18. Crucitti F, Sofo L, Ratto C, et al. Colorectal cancer: epidemiology, etiology, patogenesis and prevention. Rays 1995; 20:121-131.
19. Wilmink ABM. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997; 40:483-493.
20. Parkin DM, Stejernasward J, Muir CS. Estimates of the world-wide frequency of twelve major cancers. Bull WHO 1984; 62:163-182.
21. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in differente countries, with special reference to dietary practices. Int J Cancer 1975; 15:617-631.
22. Haenzel W, Berg JW, Berg M, et al. Large bowel cancer in Hawaiian japanese. J Natl Cancer Insti 1973; 51:1.765-1.799.
23. Goldbohm RA, Van der Brandt PA, Van't Veer P, et al. A prospective cohort study on the relation between meat consumtion and the risk of colon cancer. Cancer Res 1994; 54:718-723.
24. Willet WC, Stamffer MJ, Colditz GA, et al. Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 326:1.664-1.672.
25. Statland BE. Nutrition and cancer. Clin Chem 1992; 38:1.587-1.594.
26. Nauss KM, Jacobs LR, Newberne PM. Dietary fat and fiber: relation to caloric intake, body growth and colon tumorigenesis. Am J Clin Nutr 1987; 45:243-251.
27. Giovannucci E, Rimm EB, Stampfer MJ, et al. Intake of fat, meat and fiber in relation to risk of colon cancer in men. Cancer Res 1994; 54:2.390-2.397.
28. Ferguson LR. Diet and the prevention of colorectal cancer. Mutation Research 1993; 290:139-143.
29. Steinmetz K, Potter J. Vegetables, fruit and cancer. Cancer Causes Control 1991; 58:195-198.
30. Weisburger JH. Causes, relevant mechanisms and prevention of large bowell cancer. Semin Oncol 1991; 18:316-336.
31. Hill MJ. Microbes and human carcinogenesis. Londres: Edward Arnold, 1986.
32. Reddy BS, Narisawa T, Maronpot R, et al. Animal models for study of dietary factors and cancer of the large bowel. Cancer Res 1975; 35:3.421-3.426.
33. Burkitt DS. Etiology and prevention of colorectal cancer. Hospital Practice 1984; 67-77.
34. Cheah PY. Hypotheses for etiology of colorectal cancer: an overview. Nutr Cancer 1990; 14:5-13.
35. Matos M. Etiología del cáncer colorrectal. Gen 1994; 48:264-272.
36. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87:159-170.
37. Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997; 93:84-99.
38. Lynch HT, Lynch JF. Genetic of colonic cancer. Digestion 1998; 59:481-492.
39. Ames BN. Dietary carcinogesis and anticarcinogens. Science 1983; 221:1.256-1.264.
40. Robertson AM. Roles of endogenous substances and bacteria in colorectal cancer. Mutat Res 1993; 290:71-78.
41. Miller AB, Berrino F, Hill M, et al. Diet in the aetiology of cancer: a review. Eur J Cancer 1994; 30:207-220.
42. Van Tassell RL, Kingston DG, Wilkins TD. Metabolism of dietary genotoxins by the human colonic microflora: the fecapentaenes and heterocyclic amines. Mutat Res 1990; 238:209-221.
43. Nagao M, Sugimura T. Carcinogenic factors in food with relevance to colon cancer development. Mutat Res 1993; 290:43-51.
44. Erhardt JG, Lim SS, Bode JC, et al. A diet rich in fat and poor in dietary fiber increases in the in vitro formation of reactive oxygen species in human feces. J Nutr 1997; 127:706-709.
45. Barra S, Negri E, Franceschi S, et al. Alcohol and colorectal cancer: a case-control from norhern Italy. Cancer causes and control 1992; 3:153-159.
46. Babbs GF. Free radicals and the etiology of colon cancer. Free Radic Biol Med 1990; 8:191-200.
47. Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radie Biol Med 1995; 18:1.033-1.037.
48. Sakaguchi M, Minoura T, Hiramatsu Y, et al. Effects of dietary saturated and unsaturated fatty acids on fecal bile acids and colon carcinogenesis induced by azoxmetano in rats. Cancer Res 1986; 46:61-65.
49. Reddy BS, Sharma C, Simi B. Metabolic epidemiology of colon cancer: effects of dietary fiber on fecal mutagens and biliar acids in healthy subjects. Cancer Res 1987; 47:644-648.
50. Chaplin MF. Bile acids, fiber and colon cancer: the story unfolds. J Roy Soc Health 1998; 118:53-61.
51. Young-In K. Diet, lifestyle and colorectal cancer: is hyperinsulinemia the missing link?
52. Stone WL, Papas AM. Tocopherols and the etiology of colon cancer. J Natl Cancer Inst 1997; 89:1.006-1.013.
53. Martínez ME, Willett WC. Calcium, vitamin D and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiology, Biomarkers and Prevention 1998; 7:163-168.
54. Poter JD. Hormones and colon cancer. J Natl Cancer Inst 1995; 87:1.039-1.040.
55. Martinez ME, Grodstein F, Giovannucci E, et al. A prospective study of reproductive factors, oral contraceptive use and risk of colorectal cancer. Cancer Epidemiology, Biomarkers and Prevention 1997; 6:1-5.
56. Garewal HS. Aspirin in the prevention of colorectal cancer. Ann Intern Med 1994; 121:303-304.
57. Marcus AJ. Aspirin as prophylaxis against colorectal cancer. N Engl J Med 1995; 333:656-657.
58. Itzkowitz SH. Inflamatory bowel disease and cancer. Gastroenterol Clin North Am 1997; 26:121-139.
59. Howell MA. The association between colorectal cancer and breast cancer. J Chronic Dis 1976; 29:243-261.
60. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64:235-248.
61. Stoler AB. Genes and cancer. Brit Med Bull 1991; 47:64-75.
62. Bodmer WF. Cancer genetics. Brit Med Bull 1994; 50:517-526.
63. Lazo PA. Alteraciones genéticas en el carcinoma de colon. Med Clin 1992; 99:350-354.
64. Hamilton SR. The molecular genetics of colorectal neoplasia. Gastroenterology 1993; 105:3-7.
65. Scott N, Quirke P. Molecular biology of colorectal neoplasia. Gut 1993; 34:289-292.
66. Boland R. Genetic pathways to colorectal cancer. Hospital Practice 1997; 15:79-94.
67. Howe JR, Guillem JG. The genetics of colorectal cancer. Surg Clin North Am 1997; 77:175-195.
68. Hoops TC, Traber PG. Molecular pathogenesis of colorectal cancer. Hematol/Oncol Clin North Am 1997; 11:609-633.
69. Barbacid M. Ras genes. Annu Rev Biochem 1987; 56:779-827.
70. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4.682-4.689.
71. Forrester K, Almoguera C, Han K, et al. Detection of high incidence of k-ras oncogenes during human colon tumorigenesis. Nature 1987; 327:298-303.
72. Bos JL, Fearon ER, Hamilton SR. Prevalence of ras gene mutation in human colorectal cancers. Nature 1987; 327:293-297.
73. Pretlow TP. Aberrant crypt foci and k-ras mutations: earliest recognised players or innocent bystanders in colon carcinogenesis. Gastroenterology 1995; 108:600-603.
74. Sikora K, Chan S, Evan G, et al. C-myc oncogene expression in colorectal cancer. Cancer 1987; 59:1.289-1.295.
75. Finley GG, Schulz NT, Hill SA. Expression of the myc gene family in different stages of human colorectal cancer. Oncogene 1989; 4:963-971.
76. Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246:1.406-1.412.
77. Marshall CJ. Tumor suppressor genes. Cell 1991; 64:313-326.
78. Weinberg RA. Tumor suppressor genes. Science 1991; 254:1.138-1.145.
79. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 1971; 68:820-823.
80. Knudson AG. Hereditary cancer: two hists revisited. J Cancer Res Clin Oncol 1996; 122:135-140.
81. Stanbridge EJ, Der CJ, Doersen CJ, et al. Human cell hybrids: analysis of transformation and tumorigenicity. Science 1982; 215:252-259.
82. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature 1987; 329:219-222.
83. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66:589-600.
84. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253:661-665.
85. Miyoshi Y, Nagase H, Hiroshi A, et al. Somatic mutations of APC gene in colorectal tumors: mutation cluster region in the APC gene. Human Molecular Genetics 1992; 1:229-233.
86. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253:665-669.
87. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359:235-237.
88. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Characteristics of somatic mutations of adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994; 54:3.011-3.020.
89. Kinzler KW, Nilbert MF, Vogelstin B, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991; 251:1.366-1.370.
90. Levine AJ, Momand J, Finaly CA. The p53 tumor suppressor gene. Nature 1991; 351:453-456.
91. Vogelstein B, Kinzier KW. p53 function and dysfunction. Cell 1992; 70:523-526.
92. Hollstein M, Sidran Sky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991; 253:49-53.
93. Rotter V, Prokocimer M. p53 and human malignancies. Adv Cancer Res 1991; 57:257-272.
94. Van den Berg FM, Tigges AJ, Schipper MEI, et al. Expression of the nuclear oncogene p53 in colorectal tumors. J Pathol 1989; 157:193-199.
95. Rodrigues NR, Rowan A, Smith ME, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci 1990; 87:7.555-7.559.
96. Hamlein R, Laurent-Puig P. p53 et cancers colorectaux. Path Biol 1997; 45:876-881.
97. Srivastava S, Zou Z, Pirollo K, et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348:747-751.
98. Fearon ER, Cho KR, Nigro JM. Identification of a chromosomal 181 gene that is altered in colorectal cancers. Science 1990; 247:49-56.
99. Gryfe R, Swalow C, Bapat B, et al. Molecular biology of colorectal cancer. Current Problems in Cancer 1997; 21:238-299.
100. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate rumor suppressor gene at human chromosome 18q21. Science 1996; 271:350-353.
101. Eppert K, Scherer SW, Ozcelik H. MADR2 maps to 18q21 and encodes a TGF beta-regulated protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86:543-552.
102. Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995; 109:1.685-1.699.
103. Tribodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260:816-819.
104. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2:169-174.
105. Lynch HT, Lemon SJ, Karr B, et al. Etiology, natural histology, management and molecular genetics of hereditary non-polyposis colorectal cancer (Lynch syndrome): genetic counseling implications. Cancer Epidemiology Biomarkers and Prevention 1997; 6:987-991.
106. Feinberg AP, Gehrke CW, Kuo KC, et al. Reduce genomic 5-methyl-cytosine content in human colonic neoplasia. Cancer Res 1988; 48: 1.159-1.161.
107. Martínez JA, Prevot S, Nordlinger B, et al. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinoma and loss of nm23-H1 expression in advances tumour stages. Gut 1995; 37:712-720.
108. MacPhee M, Chepenik KP, Liddell RA, et al. The secretory fosfolipase A2 gene is a candidate for the Mom-1 locus, a major modifier of Ape Min-induced intestinal neoplasia. Cell 1995; 81:957-966.
109. Minchin RF, Kadlubar FF, Ollet KF. Role of acetylation in colorectal cancer. Mutation Res 1993; 290:35-42.
110. Midgley R, Kerr D. Towards post-genomic investigations of colorectal cancer. Lancet 2000; 355:669-670.
111. Heaney AP, Singson R, McCabe Ch J, et al. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000; 355:716-719.
112. Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249:970-971.
113. Preston-Martin S, Pike MC, Ross RK, et al. Increased cell division as a cause of human cancer. Cancer Res 1990; 50:715-721.
114. Tomlinson I, Illyas M, Novelli M. Molecular genetics of colon cancer. Cancer and Metastasis Reviews 1997; 16:67-79.
115. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
116. Caldés Llopis T. Alteraciones genéticas en el cáncer colorrectal. Rev Cancer 1999; 13:59-67.